Trial intelligence / Profile preview

Atomized salbutamol during tonsillectomy in children

ChiCTR2200060369Phase 4Recruiting

Sponsor
Taizhou People's Hospital
Start
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of salbutamol in respiratory complication (2 arms), sponsored by Taizhou People's Hospital. Primary endpoint: Respiratory complications. Started May 2022; status: recruiting.

02

Drugs

salbutamol
03

Conditions

respiratory complication

Beyond the preview

Go deeper on ChiCTR2200060369.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200060369.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call